Search research articles
Contact Us
Filters
Showing results (221-230 of 551) with videos related to
Page
of 56
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2007
Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease
Veronique Erard, Meei-Li Huang, James Ferrenberg, et al.
The Journal of Infectious Diseases
|
August 26, 2017
Valganciclovir for the Suppression of Epstein-Barr Virus Replication
Jessica E Yager, Amalia S Magaret, Steven R Kuntz, et al.
Clinical Investigation
|
December 18, 2012
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, et al.
The Journal of Infectious Diseases
|
February 4, 2011
Persistent genital herpes simplex virus-2 shedding years following the first clinical episode
Warren Phipps, Misty Saracino, Amalia Magaret, et al.
Journal of Virology
|
June 5, 2015
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
Sita Awasthi, Gregory G Mahairas, Carolyn E Shaw, et al.
The Journal of Infectious Diseases
|
February 3, 2006
High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection
Chia C Wang, Chihiro Morishima, Minjun Chung, et al.
The Journal of Infectious Diseases
|
May 22, 2008
Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial
Corey Casper, Elizabeth M Krantz, Lawrence Corey, et al.
Blood
|
July 7, 2005
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
Stefan Schwartz, Markus Ruhnke, Patricia Ribaud, et al.
Viruses
|
October 26, 2021
Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
Jim Boonyaratanakornkit, Anton M Sholukh, Matthew Gray, et al.
American Journal of Obstetrics and Gynecology
|
July 4, 2006
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes
Elizabeth L Brown, Rhoda Morrow, Elizabeth M Krantz, et al.
Page
of 56
Search research articles
Search
Showing results (221-230 of 551) with videos related to
Sort By:
Page
of 56
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2007
Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease
Veronique Erard, Meei-Li Huang, James Ferrenberg, et al.
The Journal of Infectious Diseases
|
August 26, 2017
Valganciclovir for the Suppression of Epstein-Barr Virus Replication
Jessica E Yager, Amalia S Magaret, Steven R Kuntz, et al.
Clinical Investigation
|
December 18, 2012
HIV Vaccine Trials Network: activities and achievements of the first decade and beyond
James G Kublin, Cecilia A Morgan, Tracey A Day, et al.
The Journal of Infectious Diseases
|
February 4, 2011
Persistent genital herpes simplex virus-2 shedding years following the first clinical episode
Warren Phipps, Misty Saracino, Amalia Magaret, et al.
Journal of Virology
|
June 5, 2015
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
Sita Awasthi, Gregory G Mahairas, Carolyn E Shaw, et al.
The Journal of Infectious Diseases
|
February 3, 2006
High serum hepatitis C virus (HCV) RNA load predicts the presence of HCV RNA in saliva from individuals with chronic and acute HCV infection
Chia C Wang, Chihiro Morishima, Minjun Chung, et al.
The Journal of Infectious Diseases
|
May 22, 2008
Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial
Corey Casper, Elizabeth M Krantz, Lawrence Corey, et al.
Blood
|
July 7, 2005
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
Stefan Schwartz, Markus Ruhnke, Patricia Ribaud, et al.
Viruses
|
October 26, 2021
Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
Jim Boonyaratanakornkit, Anton M Sholukh, Matthew Gray, et al.
American Journal of Obstetrics and Gynecology
|
July 4, 2006
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes
Elizabeth L Brown, Rhoda Morrow, Elizabeth M Krantz, et al.
Page
of 56